traditional medicine

Tamil Nadu government promotes Siddha medicine for dengue but doubts loom about its scientific basis

Health authorities and the National Institute of Siddha have been distributing a decoction called nilavembu kudineer prescribed in Siddha texts.

Over the past few months, the Tamil Nadu government has been distributing a brown herbal decoction at street corners, bus stops and railway stations in an attempt to combat the surge of dengue and fever cases across the state. The decoction is a Siddha medicine made from nine herbs and is called nilavembu kudineer.

Both the Union Ministry of AYUSH and the Tamil Nadu government have issued health advisories recommending nilavembu kudineer in small daily doses both to prevent getting dengue infection and to manage symptoms in infected people. In fact, Tamil Nadu health authorities have been distributing the medicine as a treatment for dengue for several years, including in the aftermath of the floods that ravaged Chennai and many parts of Tamil Nadu in 2015.

But there are significant doubts about the efficacy of the medicine, whether it induces any side-effects, and whether there is enough public awareness that it is not a substitute for standard allopathic management of the viral infection.

As per standard allopathic practice, there is no cure for dengue and treatment consists of managing symptoms until a patient recovers. The government advisories promoting the use of nilavembu kudineer also indicate that the Siddha medicine is meant to control symptoms and is supposed to work as an antipyretic (a substance that reduces fever) and an analgesic (substance that reduces pain). The Siddha advisories also mention the use of papaya juice, a common home remedy that is supposed to increase blood platelet count.

The science behind it

Siddha practitioners at the National Institute of Siddha in Chennai say that they started distributing nilavembu kudineer as a treatment for fevers 13 years ago. In 2013, Siddha researchers from the institute conducted a study in which they looked at groups of people with and without fever who visited a hospital at the institute and asked them if they had taken the the herbal medicine. Based on the information, the authors of the study concluded that the “analysis including all these subjects as Nilavembu taken group shows reduced preventive effect of the drug. When more than five days taken group is considered, the effect of Nilavembu has increased significantly against the development of viral fever related conditions (sic).”

M Subramaniam, senior researcher at the institute who co-authored the study, said, “The Tamil Nadu government has used that as a basis for declaring nilavembu kudineer to be used to tackle dengue.”

But a critique of the study shows how the authors might have not used the appropriate methodology to test for a medicine and that the study has been poorly designed.

Vijayprasad Gopichandran, assistant professor of community medicine at ESIC Medical College and Post Graduate Institute of Medical Science and Research in Chennai, notes that this is a case controlled study, the design of which is suitable to understanding risk factors of a disease and not to testing the protective, preventive or therapeutic effect of a drug or medicinal herb.

He also points out that there are confounding factors that might have affected the analysis. For instance, the authors report that the group without fever has a greater probability of having consumed nilavembu kudineer but it is also likely that this group came from an area with a smaller burden of dengue, less mosquito breeding, better socio-economic status or greater awareness on preventing mosquito bites.

“It is not clear whether the two groups – the fever group and the control group – were comparable in all these factors,” noted Gopichandran, in a written analysis of the study. “Therefore, one cannot definitively say whether the difference in fever between the two groups was purely due to nilavembu kudineer.”

Moreover, all patients were recruited from the Siddha hospital outpatient department and their shared purpose in being there may have biased the findings.

“Ideally, [the study] should have been done in the community, where there are diverse types of people with and without fever,” said Gopichandran. “Some who believe and take Siddha medicines regularly, and some who don’t.”

Patients and visitors at the National Institute of Siddha. (Photo: Vinita Govindarajan)
Patients and visitors at the National Institute of Siddha. (Photo: Vinita Govindarajan)

In a section within the study, the authors report that the platelet counts of 10 patients with confirmed dengue increased when they were treated with nilavembu kudineer. But since there is no comparison to this small sub-study, it provides no compelling proof that the herbal medicine what changed the course of these 10 people’s illnesses.

Gopichandran says that the way evidence or proof of treatment is understood in Siddha is different from the way it is understood in modern medicine. At the same time, he observes that compelling proof of the efficacy of nilavembu kudineer to treat dengue can be achieved only with a randomised controlled trial in which there are two groups of patients with dengue that are comparable in all aspects other than the treatment given to them. Each group would need to be tested with either nilavembu kudineer or modern medicine. Only then any observed change can be attributed purely to nilavembu kudineer.

Another serious problem with the study is that it was published in the International Journal of Pharmaceutical Sciences and Research, which has been found to be a predatory journal, and thus raises questions about the credibility of the science.

A predatory journal is a term for a journal that capitalises on the pressure on scientists to constantly publish research papers by charging a fee for an article to be published, like many other good quality journals do for processing and to make their material open access, but the article may not be checked for quality or reviewed by the journal’s editors and peers in the field.

“The National Institute of Siddha have managed to publish most of their articles only in predatory journals,” said GS Seethapathy, a PhD candidate at the School of Pharmacy and Natural History Museum, University of Oslo who is researching predatory publishing.

Patients line up at the noi naadal or pathology counter at the National Institute of Siddha. (Photo: Vinita Govindarajan)
Patients line up at the noi naadal or pathology counter at the National Institute of Siddha. (Photo: Vinita Govindarajan)

Side effects?

Other doctors have also cautioned against using the nilavembu kudineer as some studies have shown possible side effects, including infertility.

Research from the Memorial Sloan Kettering Cancer Centre in the United States indicates that the herb Andrographis paniculata, which is one of the main ingredients of nilavembu kudineer, interferes with the action of chemotherapy and of blood pressure drugs. It also warns that people on anti-platelet drugs, which prevent the formation of blood clots and occurrence of heart attacks, must use Andrographis with caution.

However, none of the government advisories on nilavembu mention possible risks or side effects.

Dr V Bhanumathi, director of National Siddha Institute, said that in the 13 years that the institute has been distributing the herbal medicine, there have been no reported side effects. She alleged that the problem lay with private hospitals making nilavembu kudineer that often did not follow the Siddha guidelines to make the decoction.

“Many private hospitals prepare a decoction that is light orange in colour,” she said. “That is not how it should look. It won’t be effective if prepared in the wrong manner. The decoction preparation method is designed by our great siddhars.It has to be consumed under the guidance of qualified Siddha doctors.”

Debate among doctors

According to The Times of India, a five-member committee from the union government that visited the state to investigate the dengue outbreak said that mass treatment with nilavembu was not recommended. They said it was not the “standard treatment”, without expanding further.

However, Bhanumathi said that the fact that the government has encouraged the supply of nilavembu in all allopathic hospitals in the state is proof of its scientific validity. “Some persons are not able to tolerate the fact that people are moving towards Siddha treatment,” she said. “Will any government come forward to promote this without evidence?”

Despite the defence of the use of nilavembu kudineer by the National Siddha Institute and the Tamil Nadu health minister, others including the Tamil Nadu chapter of the Indian Medical Association have been calling for scientific validation of the herbal medicine.

“Many more trials need to be conducted to understand the consequences and side-effects of nilavembu,” said Dr A Anna, a doctor in Avadi, Chennai. “In general, a lot of people are turning to nilavembu seeking relief for fever, so the government must take the responsibility to explain these consequences and side effects.”

We welcome your comments at
Sponsored Content BY 

What hospitals can do to drive entrepreneurship and enhance patient experience

Hospitals can perform better by partnering with entrepreneurs and encouraging a culture of intrapreneurship focused on customer centricity.

At the Emory University Hospital in Atlanta, visitors don’t have to worry about navigating their way across the complex hospital premises. All they need to do is download wayfinding tools from the installed digital signage onto their smartphone and get step by step directions. Other hospitals have digital signage in surgical waiting rooms that share surgery updates with the anxious families waiting outside, or offer general information to visitors in waiting rooms. Many others use digital registration tools to reduce check-in time or have Smart TVs in patient rooms that serve educational and anxiety alleviating content.

Most of these tech enabled solutions have emerged as hospitals look for better ways to enhance patient experience – one of the top criteria in evaluating hospital performance. Patient experience accounts for 25% of a hospital’s Value-Based Purchasing (VBP) score as per the US government’s Centres for Medicare and Mediaid Services (CMS) programme. As a Mckinsey report says, hospitals need to break down a patient’s journey into various aspects, clinical and non-clinical, and seek ways of improving every touch point in the journey. As hospitals also need to focus on delivering quality healthcare, they are increasingly collaborating with entrepreneurs who offer such patient centric solutions or encouraging innovative intrapreneurship within the organization.

At the Hospital Leadership Summit hosted by Abbott, some of the speakers from diverse industry backgrounds brought up the role of entrepreneurship in order to deliver on patient experience.

Getting the best from collaborations

Speakers such as Dr Naresh Trehan, Chairman and Managing Director - Medanta Hospitals, and Meena Ganesh, CEO and MD - Portea Medical, who spoke at the panel discussion on “Are we fit for the world of new consumers?”, highlighted the importance of collaborating with entrepreneurs to fill the gaps in the patient experience eco system. As Dr Trehan says, “As healthcare service providers we are too steeped in our own work. So even though we may realize there are gaps in customer experience delivery, we don’t want to get distracted from our core job, which is healthcare delivery. We would rather leave the job of filling those gaps to an outsider who can do it well.”

Meena Ganesh shares a similar view when she says that entrepreneurs offer an outsider’s fresh perspective on the existing gaps in healthcare. They are therefore better equipped to offer disruptive technology solutions that put the customer right at the center. Her own venture, Portea Medical, was born out of a need in the hitherto unaddressed area of patient experience – quality home care.

There are enough examples of hospitals that have gained significantly by partnering with or investing in such ventures. For example, the Children’s Medical Centre in Dallas actively invests in tech startups to offer better care to its patients. One such startup produces sensors smaller than a grain of sand, that can be embedded in pills to alert caregivers if a medication has been taken or not. Another app delivers care givers at customers’ door step for check-ups. Providence St Joseph’s Health, that has medical centres across the U.S., has invested in a range of startups that address different patient needs – from patient feedback and wearable monitoring devices to remote video interpretation and surgical blood loss monitoring. UNC Hospital in North Carolina uses a change management platform developed by a startup in order to improve patient experience at its Emergency and Dermatology departments. The platform essentially comes with a friendly and non-intrusive way to gather patient feedback.

When intrapreneurship can lead to patient centric innovation

Hospitals can also encourage a culture of intrapreneurship within the organization. According to Meena Ganesh, this would mean building a ‘listening organization’ because as she says, listening and being open to new ideas leads to innovation. Santosh Desai, MD& CEO - Future Brands Ltd, who was also part of the panel discussion, feels that most innovations are a result of looking at “large cultural shifts, outside the frame of narrow business”. So hospitals will need to encourage enterprising professionals in the organization to observe behavior trends as part of the ideation process. Also, as Dr Ram Narain, Executive Director, Kokilaben Dhirubhai Ambani Hospital, points out, they will need to tell the employees who have the potential to drive innovative initiatives, “Do not fail, but if you fail, we still back you.” Innovative companies such as Google actively follow this practice, allowing employees to pick projects they are passionate about and work on them to deliver fresh solutions.

Realizing the need to encourage new ideas among employees to enhance patient experience, many healthcare enterprises are instituting innovative strategies. Henry Ford System, for example, began a system of rewarding great employee ideas. One internal contest was around clinical applications for wearable technology. The incentive was particularly attractive – a cash prize of $ 10,000 to the winners. Not surprisingly, the employees came up with some very innovative ideas that included: a system to record mobility of acute care patients through wearable trackers, health reminder system for elderly patients and mobile game interface with activity trackers to encourage children towards exercising. The employees admitted later that the exercise was so interesting that they would have participated in it even without a cash prize incentive.

Another example is Penn Medicine in Philadelphia which launched an ‘innovation tournament’ across the organization as part of its efforts to improve patient care. Participants worked with professors from Wharton Business School to prepare for the ideas challenge. More than 1,750 ideas were submitted by 1,400 participants, out of which 10 were selected. The focus was on getting ideas around the front end and some of the submitted ideas included:

  • Check-out management: Exclusive waiting rooms with TV, Internet and other facilities for patients waiting to be discharged so as to reduce space congestion and make their waiting time more comfortable.
  • Space for emotional privacy: An exclusive and friendly space for individuals and families to mourn the loss of dear ones in private.
  • Online patient organizer: A web based app that helps first time patients prepare better for their appointment by providing check lists for documents, medicines, etc to be carried and giving information regarding the hospital navigation, the consulting doctor etc.
  • Help for non-English speakers: Iconography cards to help non-English speaking patients express themselves and seek help in case of emergencies or other situations.

As Arlen Meyers, MD, President and CEO of the Society of Physician Entrepreneurs, says in a report, although many good ideas come from the front line, physicians must also be encouraged to think innovatively about patient experience. An academic study also builds a strong case to encourage intrapreneurship among nurses. Given they comprise a large part of the front-line staff for healthcare delivery, nurses should also be given the freedom to create and design innovative systems for improving patient experience.

According to a Harvard Business Review article quoted in a university study, employees who have the potential to be intrapreneurs, show some marked characteristics. These include a sense of ownership, perseverance, emotional intelligence and the ability to look at the big picture along with the desire, and ideas, to improve it. But trust and support of the management is essential to bringing out and taking the ideas forward.

Creating an environment conducive to innovation is the first step to bringing about innovation-driven outcomes. These were just some of the insights on healthcare management gleaned from the Hospital Leadership Summit hosted by Abbott. In over 150 countries, Abbott, which is among the top 100 global innovator companies, is working with hospitals and healthcare professionals to improve the quality of health services.

To read more content on best practices for hospital leaders, visit Abbott’s Bringing Health to Life portal here.

This article was produced on behalf of Abbott by the marketing team and not by the editorial staff.